• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Plastikon Healthcare Expands Voluntary Nationwide Recall of Milk of Magnesia Oral Suspension and Magnesium Hydroxide

    FDA

    Plastikon Healthcare Issues Voluntary Nationwide Recall of Milk of Magnesia

    FDA

    Plastikon Healthcare Issues Voluntary Nationwide Recall of Milk of Magnesia Oral Suspension 2400 mg/30 mL

    FDA

    Covaxin to use ViroVax’s adjuvant for longer-lasting immunity

    TOI

    Covaxin to use ViroVax’s adjuvant for longer-lasting immunity

    TOI

    Verily plans digital eye care joint venture with Santen Pharma

    FIERCE BIOTECH

    Enforcement Report - Week of June 20, 2018

    FDA

    Enforcement Report - Week of July 5, 2017

    FDA

    Comfort Gel Recalled by Tarmac Products, Inc

    FDA

    Tarmac Products, Inc., Ongoing Class II recall of Antacid Liquid Regular Strength Antacid & Anti-Gas (Aluminum hydroxide 200 mg, Magnesium hydroxide 200 mg, Simethicone 20 mg (in each 5 mL, 1 teaspoon), Mint flavor, 12 fl oz (355 mL) bottle, Distributed By: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015, NDC 0363-0073-02, UPC 3 11917 15114 4. because of Microbial Contamination of Non-Sterile Products: Lots failed microbiological testing at the 12-month time point.

    FDA

    Tarmac Products, Inc., Ongoing Class II recall of Comfort Gel Maximum Strength Antacid & Anti-Gas (Aluminum hydroxide 400 mg, Magnesium hydroxide 400 mg, Simethicone 40 mg in each 5 mL, 1 teaspoon) liquid, 12 FL OZ (355 mL) bottle, Distributed By: Walgreen Co., 200 Wilmot Road, Deerfield, IL 60015, NDC 0363-0050-02, UPC 3 11917 15115 1. because of Microbial Contamination of Non-Sterile Products: Lots failed microbiological testing at the 12-month time point.

    FDA

    Soligenix Announces Publication Successfully Demonstrating Enhanced Immunogenicity of its Heat-Stable Anthrax Vaccine

    SOLIGENIX

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.